Oscar Langendorff Institute of Physiology, University of Rostock, Rostock, Germany.
Oscar Langendorff Institute of Physiology, University of Rostock, Rostock, Germany.
Neurobiol Dis. 2018 Apr;112:79-84. doi: 10.1016/j.nbd.2018.01.005. Epub 2018 Jan 9.
Voltage-independent, Ca-activated K channels (K2.2, previously named SK2) are typically activated during a train of action potentials, and hence, are powerful regulators of cellular excitability by generating an afterhyperpolarizing potential (AHP) following prolonged excitation. In the acute in vitro epilepsy model induced in hippocampal brain slice preparations by exposure to the GABA receptor blocker gabazine (GZ), the AHP was previously shown to be significantly decreased. Here, we asked the question whether K2.2 protein degradation occurs in this model and which pathways are involved. To this end, we applied either gabazine alone or gabazine together with inhibitors of proteasomal and lysosomal protein degradation pathways, Z-Leu-Leu-Leu-CHO (MG132) and chloroquine (CQ), respectively. Western blot analysis showed a significant decrease of total K2.2 protein content in GZ-treated slices which could be rescued by concomitant incubation with MG132 and CQ. Using HEK293 cells transfected with a green fluorescent protein-tagged K2.2 construct, we demonstrated that proteasomal rather than lysosomal degradation was involved in K2.2 reduction. We then recorded epileptiform afterdischarges at hippocampal Schaffer collateral-CA1 synapses and confirmed that the GZ-induced increase was significantly attenuated by both MG132 and CQ, with MG132 being significantly more effective than CQ. Epileptiform afterdischarges were almost prevented by co-application of protein degradation inhibitors. Furthermore, epileptiform afterdischarges could be re-established by using the K2.2 blocker UCL 1684 suggesting involvement of K2.2. We conclude that in GZ-induced acute epilepsy, K2.2 degradation by proteasomal rather than lysosomal pathways plays a major role in the generation of epileptiform afterdischarges.
电压无关、钙激活的钾通道(K2.2,以前称为 SK2)通常在动作电位串中被激活,因此通过在长时间兴奋后产生超极化后电位(AHP),是细胞兴奋性的有力调节者。在通过暴露于 GABA 受体阻断剂 gabazine(GZ)在海马脑片制备物中诱导的急性体外癫痫模型中,先前已经表明 AHP 显著降低。在这里,我们提出了一个问题,即在这个模型中是否会发生 K2.2 蛋白降解,以及涉及哪些途径。为此,我们单独应用 GZ 或 GZ 与蛋白酶体和溶酶体蛋白降解途径的抑制剂,即 Z-Leu-Leu-Leu-CHO(MG132)和氯喹(CQ)联合应用。Western blot 分析显示,GZ 处理的切片中总 K2.2 蛋白含量明显减少,而与 MG132 和 CQ 同时孵育则可挽救这一减少。使用转染 GFP 标记的 K2.2 构建体的 HEK293 细胞,我们证明了蛋白酶体降解而不是溶酶体降解参与了 K2.2 的减少。然后,我们在海马 Schaffer 侧支-CA1 突触处记录癫痫样后放电,并证实 MG132 和 CQ 均可显著减弱 GZ 诱导的增加,其中 MG132 的效果明显优于 CQ。两种抑制剂的共同应用几乎可以防止癫痫样后放电。此外,使用 K2.2 阻断剂 UCL 1684 可以重新建立癫痫样后放电,这表明 K2.2 的参与。我们得出结论,在 GZ 诱导的急性癫痫中,通过蛋白酶体而不是溶酶体途径的 K2.2 降解在产生癫痫样后放电中起主要作用。